Novel Dehydroabietylamine C‐Ring Schiff Base Derivatives: Synthesis, Antiproliferative activity, DNA binding and Molecular docking
Chemistry – An Asian Journal · 2025
DOI: 10.1002/asia.202401451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Lin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antineoplastic Agents, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Sate Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University).
Abstract (Originalsprache)
A series of Dehydroabietylamine (DHAA) C‐ring Schiff derivatives, L 3 ‐L 20 , were synthesized and their in vitro cytotoxic activity against the human tumor cell lines cervix HeLa, breast MCF‐7, lung A549, liver HepG2, and the nonmalignant cell line umbilical vein HUVEC was investigated. Most of the compounds showed varying degrees of anticancer activity against HeLa cell lines while demonstrating lower toxicity to normal HUVEC cells compared to DHAA and doxorubicin (DOX), especially compound L 19 , which not only enhanced the anticancer activity of DHAA, but also significantly reduced the toxicity to normal cells, achieving a selectivity index (SI) 118 times higher than that of DHAA and 245 times higher than that of DOX. In addition, Compound L 19 induced apoptosis in HeLa cells in a dose‐dependent manner, suppressed the expression of the anti‐apoptotic protein Bcl‐2, and arrested the cell cycle at the S phase. Spectroscopic experiments and molecular docking results showed that there was a strong interaction between the compounds and DNA. All these results indicate that the introduction of Schiff base structure on the C‐ring of DHAA is an effective strategy for enhancing its selectivity, providing new insights for the design of DHAA‐based anticancer compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Science, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China.
- School of Environment and Safety Engineering, Nanjing Polytechnic Institute, Nanjing, Jiangsu, 210048, China.
- The Advanced Analysis and Testing Center, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China.
ORCID-Profile: Wen Lu
Förderung
- Sate Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University)
Zitieren
APA
Li, L., Lu, W., Xue, H., Yang, S., Zhou, M., & Xu, L. (2025). Novel Dehydroabietylamine C‐Ring Schiff Base Derivatives: Synthesis, Antiproliferative activity, DNA binding and Molecular docking. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202401451
Vancouver
Li L, Lu W, Xue H, Yang S, Zhou M, Xu L. Novel Dehydroabietylamine C‐Ring Schiff Base Derivatives: Synthesis, Antiproliferative activity, DNA binding and Molecular docking. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202401451
BibTeX
@article{Li2025,
author = {Li, Lin and Lu, Wen and Xue, Huayu and Yang, Shilong and Zhou, Mengyi and Xu, Li},
title = {Novel Dehydroabietylamine C‐Ring Schiff Base Derivatives: Synthesis, Antiproliferative activity, DNA binding and Molecular docking},
journal = {Chemistry – An Asian Journal},
year = {2025},
doi = {10.1002/asia.202401451}
}
EUVIMED